Efforts To Quickly Develop Swine Flu Vaccine Reported In GEN

Main Category: Swine Flu
Also Included In: Immune System / Vaccines;  Clinical Trials / Drug Trials;  Genetics
Article Date: 03 Jun 2009 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


Scientists around the world are accelerating their efforts to develop a vaccine against the H1N1 influenza virus (Swine flu) as rapidly as possible, reports Genetic Engineering & Biotechnology News (GEN). The need for such a vaccine received a strong impetus from the World Health Organization, which has issued a Phase 5 pandemic alert, a strong signal that the WHO believes a pandemic is imminent, according to the June 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2938).

"It can take five or six months to come up with an entirely novel influenza vaccine," says John Sterling, Editor in Chief of GEN. "There is a great deal of hope that biotech and pharma companies might be able to have something ready sooner."

One company, Replikins, actually predicted over a year ago that significant outbreaks of the H1N1 flu virus would occur within 6-12 months. The predictions were based on correlations of flu virus specimens and PubMed documentation of major outbreaks during the past 90 years, focusing on concentrations of, and spacings between, replikins - the lysine and histidine residues in the hemagglutinin (HA) unit genetic sequences of the eight major genes in the influenza virus. Replikins' officials say the company's PanFLu™ vaccine is ready for clinical trials.

Novavax plans to create a virus-like particle-based (VLP) vaccine against the H1N1 strain, which obviates the need for a live virus seed for manufacturing. The VLPs contain the proteins that make the virus' outer shell and the surface proteins, without the RNA required for replication.

Other H1N1 vaccine programs covered in the GEN article include those at Medicago, VaxInnate, NanoBio, Vaxart, Pulmatrix, and Purdue University.

Source:
John Sterling
Mary Ann Liebert, Inc./Genetic Engineering News

Article adapted by Medical News Today from original press release.
Visit our swine flu section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
John Sterling. "Efforts To Quickly Develop Swine Flu Vaccine Reported In GEN." Medical News Today. MediLexicon, Intl., 3 Jun. 2009. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/152456.php>

APA
John Sterling. (2009, June 3). "Efforts To Quickly Develop Swine Flu Vaccine Reported In GEN." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/152456.php.

Please note: If no author information is provided, the source is cited instead.


Swine Flu

Most Popular Articles



Follow Our Swine Flu News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Swine Flu Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »